These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16880232)

  • 1. Complementary and alternative medicine during cancer treatment: beyond innocence.
    Tascilar M; de Jong FA; Verweij J; Mathijssen RH
    Oncologist; 2006; 11(7):732-41. PubMed ID: 16880232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herb-drug interactions in oncology: focus on mechanisms of induction.
    Meijerman I; Beijnen JH; Schellens JH
    Oncologist; 2006; 11(7):742-52. PubMed ID: 16880233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medical therapies for children with cancer.
    Kelly KM
    Eur J Cancer; 2004 Sep; 40(14):2041-6. PubMed ID: 15341976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicine (CAM) and cancer: the kind face of complementary medicine.
    Ernst E
    Int J Surg; 2009 Dec; 7(6):499-500. PubMed ID: 19716449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
    Swarup AB; Barrett W; Jazieh AR
    Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
    Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
    Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany.
    Laengler A; Spix C; Seifert G; Gottschling S; Graf N; Kaatsch P
    Eur J Cancer; 2008 Oct; 44(15):2233-40. PubMed ID: 18809313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward an understanding of decision making on complementary and alternative medicine use in poorer countries: the case of cancer care in Pakistan.
    Tovey P; Chatwin J; Ahmad S
    Integr Cancer Ther; 2005 Sep; 4(3):236-41. PubMed ID: 16113031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use and perceived benefit of complementary and alternative medicine among Californians with cancer.
    Goldstein MS; Lee JH; Ballard-Barbash R; Brown ER
    Psychooncology; 2008 Jan; 17(1):19-25. PubMed ID: 17410526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The other side of the coin: safety of complementary and alternative medicine.
    Myers SP; Cheras PA
    Med J Aust; 2004 Aug; 181(4):222-5. PubMed ID: 15310261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary-alternative medicine among cancer patients in the western region of Turkey.
    Tarhan O; Alacacioglu A; Somali I; Sipahi H; Zencir M; Oztop I; Dirioz M; Yilmaz U
    J BUON; 2009; 14(2):265-9. PubMed ID: 19650177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
    Hök J; Forss A; Falkenberg T; Tishelman C
    Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
    Marchetti S; Mazzanti R; Beijnen JH; Schellens JH
    Oncologist; 2007 Aug; 12(8):927-41. PubMed ID: 17766652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.
    Humpel N; Jones SC
    Eur J Cancer Care (Engl); 2006 Sep; 15(4):362-8. PubMed ID: 16968318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety issues in using complementary and alternative medicine.
    Markman M
    J Clin Oncol; 2002 Sep; 20(18 Suppl):39S-41S. PubMed ID: 12235223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine use in patients with fractures.
    Sprague S; Lutz K; Bryant D; Farrokhyar F; Zlowodzki M; Bhandari M
    Clin Orthop Relat Res; 2007 Oct; 463():173-8. PubMed ID: 17960679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine use in British Columbia--a survey of HIV positive people on antiretroviral therapy.
    Dhalla S; Chan KJ; Montaner JS; Hogg RS
    Complement Ther Clin Pract; 2006 Nov; 12(4):242-8. PubMed ID: 17030295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.